Trial intelligence / Profile preview

Goreisan for prevention of postoperative nausea and vomiting in laparoscopic gynecologic surgery

jRCT1091220060Completed

Sponsor
Kori
Start
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of oreongsan in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Kori. Primary endpoint: prevention effect of postoperative nausea and vomiting. Started Jun 2011; status: completed.

02

Drugs

oreongsan
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on jRCT1091220060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1091220060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call